Cargando…

Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview

BACKGROUND: Pharmacist involvement in the prevention of medication errors is well documented. One such method, the process by which hospital pharmacists undertake these clinical interventions needs to be described and documented. The perceived barriers to pharmacists succeeding in getting their reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Acheampong, Franklin, Anto, Berko Panyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562207/
https://www.ncbi.nlm.nih.gov/pubmed/26345278
http://dx.doi.org/10.1186/s12913-015-1031-9
_version_ 1782389137119117312
author Acheampong, Franklin
Anto, Berko Panyin
author_facet Acheampong, Franklin
Anto, Berko Panyin
author_sort Acheampong, Franklin
collection PubMed
description BACKGROUND: Pharmacist involvement in the prevention of medication errors is well documented. One such method, the process by which hospital pharmacists undertake these clinical interventions needs to be described and documented. The perceived barriers to pharmacists succeeding in getting their recommendations accepted could inform future safety strategy development. This study was therefore to trace the typical process involved and explore the perceived barriers to pharmacists’ medication safety efforts. METHODS: This study involved a retrospective evaluation of routine clinical interventions collected at a tertiary hospital in Ghana over 23 months. A sample of pharmacists who had submitted these reports were then interviewed. RESULTS: The interventions made related to drug therapy changes (76.0 %), monitoring (13.0 %), communication (5.4 %), counselling (5.0 %) and adverse drug events (0.6 %). More than 90 % of interventions were accepted. The results also showed that undertaking clinical interventions by pharmacists followed a sequential order with two interlinked subprocesses: Problem Identification and Problem Handling. In identifying the problem, as much information needed to be gathered, clinical issues identified and then the problems prioritised. During the problem handling stage, detailed assessment was made which led to the development of a pharmaceutical plan. The plan was then implemented and monitored to ensure appropriateness of desired outcomes. The main barrier mentioned by pharmacist related to the discrepant attitudes of doctors/nurses. The other barriers encountered during these tasks related to workload, and inadequate clinical knowledge. The attitudes were characterised by conflicts and egos resulting from differences in status/authority, responsibilities, and training. CONCLUSIONS: Though the majority of recommendations from pharmacists were accepted, the main barrier to hospital pharmacist engagement in medication error prevention activities related to discrepant attitudes of doctors and nurses. Proper initiation and maintenance of collaborative working relationship in hospitals is desired between the healthcare team members to benefit from the medication safety services of hospital pharmacists.
format Online
Article
Text
id pubmed-4562207
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45622072015-09-09 Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview Acheampong, Franklin Anto, Berko Panyin BMC Health Serv Res Research Article BACKGROUND: Pharmacist involvement in the prevention of medication errors is well documented. One such method, the process by which hospital pharmacists undertake these clinical interventions needs to be described and documented. The perceived barriers to pharmacists succeeding in getting their recommendations accepted could inform future safety strategy development. This study was therefore to trace the typical process involved and explore the perceived barriers to pharmacists’ medication safety efforts. METHODS: This study involved a retrospective evaluation of routine clinical interventions collected at a tertiary hospital in Ghana over 23 months. A sample of pharmacists who had submitted these reports were then interviewed. RESULTS: The interventions made related to drug therapy changes (76.0 %), monitoring (13.0 %), communication (5.4 %), counselling (5.0 %) and adverse drug events (0.6 %). More than 90 % of interventions were accepted. The results also showed that undertaking clinical interventions by pharmacists followed a sequential order with two interlinked subprocesses: Problem Identification and Problem Handling. In identifying the problem, as much information needed to be gathered, clinical issues identified and then the problems prioritised. During the problem handling stage, detailed assessment was made which led to the development of a pharmaceutical plan. The plan was then implemented and monitored to ensure appropriateness of desired outcomes. The main barrier mentioned by pharmacist related to the discrepant attitudes of doctors/nurses. The other barriers encountered during these tasks related to workload, and inadequate clinical knowledge. The attitudes were characterised by conflicts and egos resulting from differences in status/authority, responsibilities, and training. CONCLUSIONS: Though the majority of recommendations from pharmacists were accepted, the main barrier to hospital pharmacist engagement in medication error prevention activities related to discrepant attitudes of doctors and nurses. Proper initiation and maintenance of collaborative working relationship in hospitals is desired between the healthcare team members to benefit from the medication safety services of hospital pharmacists. BioMed Central 2015-09-07 /pmc/articles/PMC4562207/ /pubmed/26345278 http://dx.doi.org/10.1186/s12913-015-1031-9 Text en © Acheampong and Anto. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Acheampong, Franklin
Anto, Berko Panyin
Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title_full Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title_fullStr Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title_full_unstemmed Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title_short Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview
title_sort perceived barriers to pharmacist engagement in adverse drug event prevention activities in ghana using semi-structured interview
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562207/
https://www.ncbi.nlm.nih.gov/pubmed/26345278
http://dx.doi.org/10.1186/s12913-015-1031-9
work_keys_str_mv AT acheampongfranklin perceivedbarrierstopharmacistengagementinadversedrugeventpreventionactivitiesinghanausingsemistructuredinterview
AT antoberkopanyin perceivedbarrierstopharmacistengagementinadversedrugeventpreventionactivitiesinghanausingsemistructuredinterview